Search research articles
Contact Us
Filters
Showing results (61-70 of 131) with videos related to
Page
of 14
Sort By:
Plos One
|
December 14, 2021
Evaluation of SARS-CoV-2 in semen, seminal plasma, and spermatozoa pellet of COVID-19 patients in the acute stage of infection
Lucie Delaroche, Mélanie Bertine, Pierre Oger, et al.
The Journal of Antimicrobial Chemotherapy
|
March 11, 2015
Highly frequent HIV-1 minority resistant variants at baseline of the ANRS 139 TRIO trial had a limited impact on virological response
Charlotte Charpentier, Guinevere Q Lee, Christophe Rodriguez, et al.
Plos One
|
June 2, 2018
Evaluation of different analysis pipelines for the detection of HIV-1 minority resistant variants
Marine Perrier, Nathalie Désiré, Alexandre Storto, et al.
Microorganisms
|
July 29, 2023
Faecal Viral Excretion and Gastrointestinal Co-Infection Do Not Explain Digestive Presentation in COVID-19 Patients
Inès Rezzoug, Benoit Visseaux, Mélanie Bertine, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 19, 2015
Dolutegravir in HIV-2-Infected Patients With Resistant Virus to First-line Integrase Inhibitors From the French Named Patient Program
Diane Descamps, Gilles Peytavin, Benoit Visseaux, et al.
AIDS Research and Human Retroviruses
|
November 26, 2014
Antiretroviral-Experienced HIV-1-Infected Patients Treated with Maraviroc: Factors Associated with Virological Response
Cathia Soulie, Gilles Peytavin, Charlotte Charpentier, et al.
AIDS Research and Human Retroviruses
|
June 21, 2014
Short communication: Prevalence of HIV-1 transmitted drug resistance in Liberia
Paul Loubet, Charlotte Charpentier, Benoit Visseaux, et al.
Influenza and Other Respiratory Viruses
|
April 5, 2021
Viral epidemiology and SARS-CoV-2 co-infections with other respiratory viruses during the first COVID-19 wave in Paris, France
Quentin Le Hingrat, Donia Bouzid, Christophe Choquet, et al.
Haematologica
|
May 13, 2021
Low incidence of COVID-19 severe complications in a large cohort of children with sickle cell disease: a protective role for basal interferon-1 activation?
Valentine Brousse, Laurent Holvoet, Rémi Pescarmona, et al.
Plos One
|
January 26, 2013
Role of baseline HIV-1 DNA level in highly-experienced patients receiving raltegravir, etravirine and darunavir/ritonavir regimen (ANRS139 TRIO trial)
Charlotte Charpentier, Catherine Fagard, Céline Colin, et al.
Page
of 14
Search research articles
Search
Showing results (61-70 of 131) with videos related to
Sort By:
Page
of 14
Plos One
|
December 14, 2021
Evaluation of SARS-CoV-2 in semen, seminal plasma, and spermatozoa pellet of COVID-19 patients in the acute stage of infection
Lucie Delaroche, Mélanie Bertine, Pierre Oger, et al.
The Journal of Antimicrobial Chemotherapy
|
March 11, 2015
Highly frequent HIV-1 minority resistant variants at baseline of the ANRS 139 TRIO trial had a limited impact on virological response
Charlotte Charpentier, Guinevere Q Lee, Christophe Rodriguez, et al.
Plos One
|
June 2, 2018
Evaluation of different analysis pipelines for the detection of HIV-1 minority resistant variants
Marine Perrier, Nathalie Désiré, Alexandre Storto, et al.
Microorganisms
|
July 29, 2023
Faecal Viral Excretion and Gastrointestinal Co-Infection Do Not Explain Digestive Presentation in COVID-19 Patients
Inès Rezzoug, Benoit Visseaux, Mélanie Bertine, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 19, 2015
Dolutegravir in HIV-2-Infected Patients With Resistant Virus to First-line Integrase Inhibitors From the French Named Patient Program
Diane Descamps, Gilles Peytavin, Benoit Visseaux, et al.
AIDS Research and Human Retroviruses
|
November 26, 2014
Antiretroviral-Experienced HIV-1-Infected Patients Treated with Maraviroc: Factors Associated with Virological Response
Cathia Soulie, Gilles Peytavin, Charlotte Charpentier, et al.
AIDS Research and Human Retroviruses
|
June 21, 2014
Short communication: Prevalence of HIV-1 transmitted drug resistance in Liberia
Paul Loubet, Charlotte Charpentier, Benoit Visseaux, et al.
Influenza and Other Respiratory Viruses
|
April 5, 2021
Viral epidemiology and SARS-CoV-2 co-infections with other respiratory viruses during the first COVID-19 wave in Paris, France
Quentin Le Hingrat, Donia Bouzid, Christophe Choquet, et al.
Haematologica
|
May 13, 2021
Low incidence of COVID-19 severe complications in a large cohort of children with sickle cell disease: a protective role for basal interferon-1 activation?
Valentine Brousse, Laurent Holvoet, Rémi Pescarmona, et al.
Plos One
|
January 26, 2013
Role of baseline HIV-1 DNA level in highly-experienced patients receiving raltegravir, etravirine and darunavir/ritonavir regimen (ANRS139 TRIO trial)
Charlotte Charpentier, Catherine Fagard, Céline Colin, et al.
Page
of 14